» Articles » PMID: 18412955

Essential Role of Platelet Activation Via Protease Activated Receptor 4 in Tissue Factor-initiated Inflammation

Overview
Publisher Biomed Central
Specialty Rheumatology
Date 2008 Apr 17
PMID 18412955
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Tissue factor (TF) activation of the coagulation proteases enhances inflammation in animal models of arthritis and endotoxemia, but the mechanism of this effect is not yet fully understood - in particular, whether this is primarily due to fibrin formation or through activation of protease activated receptors (PARs).

Methods: We induced extravascular inflammation by injection of recombinant soluble murine TF (sTF1-219) in the hind paw. The effects of thrombin inhibition, fibrinogen and platelet depletion were evaluated, as well as the effects of PAR deficiency using knockout mice deficient for each of the PARs.

Results: Injection of soluble TF provoked a rapid onset of paw swelling. Inflammation was confirmed histologically and by increased serum IL-6 levels. Inflammation was significantly reduced by depletion of fibrinogen (P < 0.05) or platelets (P = 0.015), and by treatment with hirudin (P = 0.04) or an inhibitor of activated factor VII (P < 0.001) compared with controls. PAR-4-deficient mice exhibited significantly reduced paw swelling (P = 0.003). In contrast, a deficiency in either PAR-1, PAR-2 or PAR-3 did not affect the inflammatory response to soluble TF injection.

Conclusion: Our results show that soluble TF induces acute inflammation through a thrombin-dependent pathway and both fibrin deposition and platelet activation are essential steps in this process. The activation of PAR-4 on platelets is crucial and the other PARs do not play a major role in soluble TF-induced inflammation.

Citing Articles

Role of protease-activated receptor 4 in mouse models of acute and chronic kidney injury.

Erreger K, Cao S, Pan Y, Jiang M, Zhang M, Harris R Am J Physiol Renal Physiol. 2023; 326(2):F219-F226.

PMID: 38031732 PMC: 11198992. DOI: 10.1152/ajprenal.00162.2023.


Preliminary Study on Gene Regulation and its Pathways in Chinese Holstein Cows with Clinical Mastitis Caused by .

Wang W, Li R, Ye T, Zhang X, Chen C, Liang A J Vet Res. 2022; 66(2):179-187.

PMID: 35892111 PMC: 9281521. DOI: 10.2478/jvetres-2022-0022.


Exploring Diagnostic Biomarkers and Comorbid Pathogenesis for Osteoarthritis and Metabolic Syndrome via Bioinformatics Approach.

Jiang X, Zhong R, Dai W, Huang H, Yu Q, Zhang J Int J Gen Med. 2021; 14:6201-6213.

PMID: 34616175 PMC: 8487858. DOI: 10.2147/IJGM.S325561.


Antioxidant and Anti-Inflammatory Effects of and : In Silico, Biochemical and Histological Study.

Zammel N, Saeed M, Bouali N, Elkahoui S, Alam J, Rebai T Foods. 2021; 10(6).

PMID: 34203950 PMC: 8232813. DOI: 10.3390/foods10061383.


Using PAR4 Inhibition as an Anti-Thrombotic Approach: Why, How, and When?.

Li S, Tarlac V, Hamilton J Int J Mol Sci. 2019; 20(22).

PMID: 31717963 PMC: 6888008. DOI: 10.3390/ijms20225629.


References
1.
Busso N, Peclat V, van Ness K, Kolodziesczyk E, Degen J, Bugge T . Exacerbation of antigen-induced arthritis in urokinase-deficient mice. J Clin Invest. 1998; 102(1):41-50. PMC: 509063. DOI: 10.1172/JCI2312. View

2.
Skogen W, Senior R, Griffin G, Wilner G . Fibrinogen-derived peptide B beta 1-42 is a multidomained neutrophil chemoattractant. Blood. 1988; 71(5):1475-9. View

3.
Smiley S, King J, Hancock W . Fibrinogen stimulates macrophage chemokine secretion through toll-like receptor 4. J Immunol. 2001; 167(5):2887-94. DOI: 10.4049/jimmunol.167.5.2887. View

4.
Marty I, Peclat V, Kirdaite G, Salvi R, So A, Busso N . Amelioration of collagen-induced arthritis by thrombin inhibition. J Clin Invest. 2001; 107(5):631-40. PMC: 199423. DOI: 10.1172/JCI11064. View

5.
Bokarewa M, Morrissey J, Tarkowski A . Tissue factor as a proinflammatory agent. Arthritis Res. 2002; 4(3):190-5. PMC: 111021. DOI: 10.1186/ar405. View